Aperio Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $7.99M | Sell |
149,160
-3,674
| -2% | -$191K | 0.02% | 642 |
|
|
2020
Q3 | $7.17M | Sell |
152,834
-28,967
| -16% | -$1.49M | 0.02% | 596 |
|
|
2020
Q2 | $9.49M | Buy |
181,801
+19,075
| +12% | +$983K | 0.04% | 477 |
|
|
2020
Q1 | $7.8M | Buy |
162,726
+13,711
| +9% | +$712K | 0.03% | 498 |
|
|
2019
Q4 | $7.54M | Buy |
149,015
+11,740
| +9% | +$606K | 0.03% | 586 |
|
|
2019
Q3 | $6.48M | Buy |
137,275
+28,317
| +26% | +$1.29M | 0.03% | 621 |
|
|
2019
Q2 | $5.13M | Buy |
108,958
+4,164
| +4% | +$192K | 0.02% | 706 |
|
|
2019
Q1 | $5.04M | Sell |
104,794
-20,495
| -16% | -$1.03M | 0.02% | 699 |
|
|
2018
Q4 | $5.59M | Sell |
125,289
-1,005
| -0.8% | -$52.4K | 0.03% | 598 |
|
|
2018
Q3 | $6.82M | Buy |
126,294
+28,775
| +30% | +$1.47M | 0.03% | 571 |
|
|
2018
Q2 | $4.76M | Sell |
97,519
-36,730
| -27% | -$2.08M | 0.02% | 685 |
|
|
2018
Q1 | $8.41M | Buy |
134,249
+26,963
| +25% | +$1.85M | 0.04% | 486 |
|
|
2017
Q4 | $6.57M | Sell |
107,286
-6,544
| -6% | -$405K | 0.03% | 551 |
|
|
2017
Q3 | $7.62M | Sell |
113,830
-8,471
| -7% | -$599K | 0.04% | 468 |
|
|
2017
Q2 | $9.53M | Sell |
122,301
-10,594
| -8% | -$800K | 0.06% | 390 |
|
|
2017
Q1 | $10.8M | Sell |
132,895
-626
| -0.5% | -$49.3K | 0.07% | 318 |
|
|
2016
Q4 | $9.61M | Buy |
133,521
+2,249
| +2% | +$163K | 0.07% | 311 |
|
|
2016
Q3 | $10.2M | Buy |
131,272
+19,715
| +18% | +$1.59M | 0.07% | 312 |
|
|
2016
Q2 | $8.7M | Sell |
111,557
-19,392
| -15% | -$1.55M | 0.07% | 331 |
|
|
2016
Q1 | $10.7M | Buy |
130,949
+2,957
| +2% | +$240K | 0.09% | 258 |
|
|
2015
Q4 | $11.4M | Buy |
127,992
+14,860
| +13% | +$1.26M | 0.1% | 223 |
|
|
2015
Q3 | $8.69M | Buy |
113,132
+11,394
| +11% | +$952K | 0.09% | 277 |
|
|
2015
Q2 | $8.51M | Buy |
101,738
+7,663
| +8% | +$677K | 0.09% | 282 |
|
|
2015
Q1 | $8.49M | Buy |
94,075
+5,936
| +7% | +$511K | 0.1% | 259 |
|
|
2014
Q4 | $7.12M | Buy |
88,139
+10,653
| +14% | +$841K | 0.09% | 283 |
|
|
2014
Q3 | $5.8M | Buy |
77,486
+6,658
| +9% | +$484K | 0.08% | 319 |
|
|
2014
Q2 | $4.86M | Sell |
70,828
-1,203
| -2% | -$81.9K | 0.07% | 343 |
|
|
2014
Q1 | $5.04M | Buy |
+72,031
| New | +$5.01M | 0.07% | 368 |
|
|
2013
Q4 | – | Sell |
-59,848
| Closed | -$3.66M | – | 370 |
|
|
2013
Q3 | $3.12M | Buy |
59,848
+15,580
| +35% | +$792K | 0.06% | 416 |
|
|
2013
Q2 | $2.09M | Buy |
+44,268
| New | +$2.02M | 0.05% | 487 |
|
Other funds holding CAH
Aperio Group's CAH Position: Q4 2020 in Review
Aperio Group reduced its Cardinal Health (CAH) stake by 2.4% in Q4 2020, selling an estimated $191K and leaving 149,160 shares worth $7.99M. The position accounts for 0.02% of the portfolio, ranked #642.
Aperio Group first reported a position in CAH in Q2 2013 and has held it in 30 quarters since. The position peaked at $11.4M in Q4 2015. 780 funds tracked by Wall St. Rank hold CAH as of Q4 2020.
- Aperio Group held 149,160 shares of Cardinal Health worth $7.99M as of Q4 2020.
- Aperio Group sold 3,674 Cardinal Health shares in Q4 2020, an estimated $191K.
- Cardinal Health made up 0.02% of Aperio Group's portfolio in Q4 2020, its #642 holding.
- Aperio Group first reported a position in Cardinal Health in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Cardinal Health position peaked at $11.4M in Q4 2015.
- 780 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.